By preventing the production of B-cell lymphoma-extra-large (Bcl-xL), cyclin B, and the epithelial-mesenchymal transition, LCP reduced the growth and spread of intestinal cancer cells in gastric cancer (EMT). This evidence concerns the gene BCL2L1 and gastric cancer.